17: De Novo Concentration-Controlled Everolimus Is Associated with a Decreased Incidence of CMV Infection in Cardiac Transplant Recipients

Journal article

Peer reviewed

C. Bara, S.-S. Wang, A. Zuckermann, H. Ross, M. Frigerio, H.J. Eisen, G. Laufer, M. Cotrufo and A.M. Keogh

The Journal of heart and lung transplantation, v 27(2), pp S66-S66

2008

Additional Links

8 Record Views

Title: 17: De Novo Concentration-Controlled Everolimus Is Associated with a Decreased Incidence of CMV Infection in Cardiac Transplant Recipients
Creators: C. Bara - Hochschule Hannover
S.-S. Wang - University of Taipei
A. Zuckermann - Universitaet Wien Allgemaines Krankenhaus Universitaetkliniken, Vienna, Austria
H. Ross - Toronto General Hospital
M. Frigerio - Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
H.J. Eisen - Drexel University
G. Laufer - Innsbruck Medical University
M. Cotrufo - Ospedale D. Cotugno
A.M. Keogh - Saint Vincent's Catholic Medical Center
Publication Details: The Journal of heart and lung transplantation, v 27(2), pp S66-S66
Publisher: Elsevier
Resource Type: Journal article
Language: English
Web of Science ID: WOS:000253342300018
Other Identifier: 991019335233704721

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types: Domestic collaboration; International collaboration
Web of Science research areas: Cardiac & Cardiovascular Systems; Respiratory System; Surgery; Transplantation